Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56121-44-9

Post Buying Request

56121-44-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56121-44-9 Usage

Description

2',4'-Dihydroxy-4,6'-dimethoxychalcone is a natural chemical compound that belongs to the chalcone class of flavonoids. It is derived from various plant sources and exhibits a range of biological activities, such as antioxidant, anti-inflammatory, and anticancer properties. 2',4'-Dihydroxy-4,6'-dimethoxychalcone has been studied for its potential in preventing and treating various diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders. Its antioxidant properties make it a promising candidate for the development of new drugs and nutraceuticals with potential health benefits. Furthermore, its anti-inflammatory properties make it a potentially valuable substance for the treatment of inflammatory conditions. Ongoing research is exploring the potential uses of 2',4'-Dihydroxy-4,6'-dimethoxychalcone in medicine and health-related products.

Uses

Used in Pharmaceutical Industry:
2',4'-Dihydroxy-4,6'-dimethoxychalcone is used as a pharmaceutical candidate for its antioxidant and anti-inflammatory properties, making it suitable for the development of new drugs and nutraceuticals with potential health benefits.
Used in Cancer Prevention and Treatment:
2',4'-Dihydroxy-4,6'-dimethoxychalcone is used as an anticancer agent for its potential in preventing and treating various types of cancer. Its biological activities contribute to the modulation of oncological signaling pathways, exerting inhibitory effects on tumor growth and progression.
Used in Cardiovascular Disease Prevention and Treatment:
2',4'-Dihydroxy-4,6'-dimethoxychalcone is used as a preventive and therapeutic agent for cardiovascular diseases, leveraging its antioxidant properties to protect against oxidative stress and inflammation associated with these conditions.
Used in Neurodegenerative Disorder Prevention and Treatment:
2',4'-Dihydroxy-4,6'-dimethoxychalcone is used as a potential treatment for neurodegenerative disorders, with its antioxidant and anti-inflammatory properties potentially mitigating the effects of oxidative stress and inflammation in the brain.
Used in Inflammatory Condition Treatment:
2',4'-Dihydroxy-4,6'-dimethoxychalcone is used as an anti-inflammatory agent for the treatment of various inflammatory conditions, capitalizing on its ability to reduce inflammation and associated symptoms.

Check Digit Verification of cas no

The CAS Registry Mumber 56121-44-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,1,2 and 1 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 56121-44:
(7*5)+(6*6)+(5*1)+(4*2)+(3*1)+(2*4)+(1*4)=99
99 % 10 = 9
So 56121-44-9 is a valid CAS Registry Number.

56121-44-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-O-Methylhelichrysetin

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56121-44-9 SDS

56121-44-9Relevant articles and documents

Design, synthesis and biological evaluation of dimethyl cardamonin (DMC) derivatives as P-glycoprotein-mediated multidrug resistance reversal agents

Liu, Jianwen,Ma, Lei,Shi, Ximeng,Yin, Huanhuan,Zhao, Yuyu,Zhou, Licheng

, p. 1270 - 1282 (2020/10/06)

Background: P-glycoprotein (P-gp) has been regarded as an important factor in the multidrug resistance (MDR) of tumor cells within the last decade, which can be solved by inhibiting P-gp to reverse MDR. Thus, it is an effective strategy to develop inhibitor of P-gp. Objective: In this study, the synthesis of a series of derivatives had been carried out by bioisosterism design on the basis of Dimethyl Cardamonin (DMC). Subsequently, we evaluated their reversal activities as potential P-glycoprotein (P-gp)-mediated Multidrug Resistance (MDR) agents. Methods: Dimethyl cardamonin derivatives were synthesized from acetophenones and the corresponding benzaldehydes in the presence of 40% KOH by Claisen-Schmidt reaction. Their cytotoxicity and reversal activities in vitro were assessed with MTT. Moreover, the compound B4 was evaluated by Doxorubicin (DOX) accumulation, Western blot and wound-healing assays deeply. Results and Discussion: The results showed that compounds B2, B4 and B6 had the potency of MDR reversers with little intrinsic cytotoxicity. Meanwhile, these compounds also demonstrated the capability to inhibit MCF-7 and MCF-7/DOX cells migration. Besides, the most compound B4 was selected for further study, which promoted the accumulation of DOX in MCF-7/DOX cells and inhibited the expressionof P-gp at protein levels. Conclusion: The above findings may provide new insights for the research and development of P-gp-mediated MDR reversal agents.

In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones

Aponte, Jose C.,Castillo, Denis,Estevez, Yannick,Gonzalez, German,Arevalo, Jorge,Hammond, Gerald B.,Sauvain, Michel

scheme or table, p. 100 - 103 (2010/04/06)

The in vitro screening of 43 polysubstituted chalcones against Leishmania amazonensis axenic amastigotes, led to the evaluation of 9 of them in a macrophage-infected model with the two other most infectious Leishmania species prevalent in Peru (L. braziliensis and L. peruviana). The five most active and selective chalcones were studied in vivo, resulting on the identification of two chalcones with high reduction parasite burden percentages.

Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones

Aponte, José C.,Verástegui, Manuela,Málaga, Edith,Zimic, Mirko,Quiliano, Miguel,Vaisberg, Abraham J.,Gilman, Robert H.,Hammond, Gerald B.

experimental part, p. 6230 - 6234 (2009/09/25)

Synthesis of a cytotoxic dihydrochalcone, first isolated from a traditional Amazonian medicinal plant Iryanthera juruensis Warb (Myristicaceae), followed by a comprehensive SAR analysis of saturated and unsaturated chalcone synthetic intermediates, led to the identification of analogues with selective and significant in vitro anti-Trypanosoma cruzi activity. Further SAR studies were undertaken with the synthesis of 21 new chalcones containing two allyloxy moieties that resulted in the discovery of 2′,4′-diallyloxy- 6′-methoxy chalcones with improved selectivity against this parasite at concentrations below 25 μM, four of which exhibited a selectivity index greater than 12.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56121-44-9